Use of Anti – VEGF Therapy for ROP: When and How

Related

• 

  Association Between DRSS Changes and Visual/ Anatomic Outcomes in Patients With Moderately Severe to Severe NPDR: Post Hoc Analysis of PANORAMA

  Diana V Do, MD, FASRS

  Annual Meeting Talks

  2022

• 

  Results of Perimetry at Age of 10 Years in Severe ROP Eyes Receiving Laser or Anti-VEGF Treatment as Primary Monotherapy

  Alay S. Banker, MD

  Annual Meeting Talks

  2020

• 

  Intermittent to Continuous Therapy for Diabetic Macular Edema leads to Reduction in Treatment Frequency and Reduced Retinal Thickness Fluctuations

  Seenu M. Hariprasad, MD

  On Demand Cases, Courses, and Papers

  2019